October 14 Weekly Round-Up: NEC Members Contribute to COVID-19 Crisis Response

As our region and our nation continue to grapple with the Coronavirus Disease (COVID-19) pandemic, The New England Council is using our blog as a platform to highlight some of the incredible work our members have undertaken to respond to the outbreak. Once a week, we’ll post a round-up of updates on some of the initiatives underway among Council members throughout the region.  We are also sharing these updates via our social media, and encourage our members to share with us any information on their efforts so that we can be sure to include them in these weekly round-ups.

You can find all the Council’s information and resources related to the crisis in the special COVID-19 section of our website.  This includes our COVID-19 Virtual Events Calendar, which provides information on upcoming COVID-19 Congressional town halls and webinars presented by NEC members, as well as our Federal Agency COVID-19 Guidance for Businesses page.

Here is today’s (October 14, 2020) roundup:

  • UMass Study Finds that Seniors are Often Excluded From COVID-19 Trials – A University of Massachusetts Medical School affiliated study has found that seniors, who are often the most at risk for COVID-19, are excluded by more than half of COVID-19 clinical trials. The study made recommendations for future trials, in including more patients in this demographic. Read more here.
  • Harvard Medical School and Mass General Publish Study on Protective Antibodies – Researchers at Harvard Medical School and Massachusetts General Hospital have found that protective antibodies in patients who survive serious COVID-19 infections may provide longer protection against the virus. The study offers further insight into how long antibodies may remain in the system and provides recommendations for further antibody testing. Read more here.
  • Beth Israel Medical Center Launches Clinical Trial for Antiviral COVID-19 TreatmentBeth Israel Deaconess Medical Center has launched a new study on antiviral treatment for patients at home with COVID-19. The TREAT-NOW study is being conducted in tandem with Vanderbilt University and the University of Colorado to see if a well-known antiviral drug can help prevent or mitigate serious COVID-19 symptoms. Read more here.
  • New Tool Developed at Mass General Helps Predict Outbreaks in Counties that Host Pro Football Games – Researchers at Massachusetts General Hospital have expanded the scope of their COVID-19 Outbreak Detection Tool to incorporate NFL and NCAA football games as potential super-spreader events. The tool will be used to help inform public health and team executives about potential outbreaks. Read more here.

Stay tuned for more updates each day, and follow us on Twitter for more frequent updates on how Council members are contributing to the response to this global health crisis.

 

img_side
mask_sidebar
Recently from the Blog

October 21 Weekly Round-Up: NEC Members Contribute to COVID-19 Crisis Response

10/21/2020 | Read Post

AVANGRID Named One of Forbes Best-In-State Employers 2020

10/19/2020 | Read Post

In the News

NEC Elects Six Respected Regional Business Leaders to Board of Directors

09/28/2020 | Read Press Release

NEC Announces 2020 New Englanders of the Year

08/25/2020 | Read Press Release